American Healthcare REIT Share Price Drop Sparks Concern Over Broker Recommendations
Investors in American Healthcare REIT, a real estate investment trust listed on the New York Stock Exchange, are facing financial losses after its share price dropped 3% on August 6, 2024. The decline raises concerns about broker recommendations and suitability, particularly for inexperienced investors and conservative retirees. The REIT's portfolio, valued at approximately $4.6 billion, includes medical office buildings, skilled nursing facilities, and hospitals. Investors are questioning whether their brokers inappropriately recommended the REIT, citing high commissions and fees associated with these investments. Broker-dealers may have breached their fiduciary duty by failing to conduct proper due diligence, leading to unsuitable exposure and significant losses for investors.
Key Takeaways:
- American Healthcare REIT's share price dropped 3% on August 6, 2024, raising concerns about broker recommendations and suitability.
- The REIT's portfolio includes medical office buildings, skilled nursing facilities, and hospitals, valued at approximately $4.6 billion.
- High commissions and fees associated with REITs may have led to inappropriately marketed investments to inexperienced investors and conservative retirees.
- Broker-dealers may have breached their fiduciary duty by failing to conduct proper due diligence, resulting in unsuitable exposure and significant losses.
- Legacy investors in the REIT purchased 66 million shares for $40/share, while new investors bought 56 million shares in an IPO for $12/share.
- The REIT's estimated net asset value (NAV) for Class I and Class T common stock in March 2023 was $31.40/share, following a 4-1 reverse stock split.
- Comrit made a third-party tender offer to buy 228,136 of the REIT's shares at an 8% reduction.
- American Healthcare REIT's share repurchase plan was suspended in 2022, and quarterly distributions for Class T and Class I common stockholders were reduced in March 2023.
Statistics:
- 3%: The decline in American Healthcare REIT's share price on August 6, 2024.
- 56 million: The number of shares issued in the REIT's IPO.
- $12: The IPO price per share.
- 66 million: The number of shares purchased by legacy investors.
- $40: The price per share paid by legacy investors.
- $4.6 billion: The total value of the REIT's portfolio as of September 2023.
- 8%: The reduction offered by Comrit in its third-party tender offer.
- $31.40: The estimated net asset value (NAV) per share for Class I and Class T common stock in March 2023.
- 4-1: The ratio of the reverse stock split in March 2023.
Sources:
- Shepherd Smith Edwards & Kantas LLP (Shepherd Smith Edwards and Kantas ( [www.sshekan.com](http://www.sshekan.com) ) is offering free, no obligation case consultations to )
- American Healthcare REIT (A product of the merger between Griffin-American Healthcare REIT III, Griffin-American Healthcare REIT IV, and American Healthcare Investors, in February 2024, AHR arrived on the New York Stock Exchange with a 56 million share/IPO at $12/share.)